Elixxer

Elixxer Book Value per Share

The Book Value per Share of Elixxer (ELXR.H.V) as of Oct 16, 2026 is -0.10 CAD. In the previous year, Book Value per Share was -0.06 CAD — a change of 71.90% (lower).

Book Value per Share

-0.10CAD

YoY

71.90%

Last updated:

Book Value per Share of Elixxer is 2023 -0.10 CAD. Book Value per Share of Elixxer was 2022 -0.06 CAD. It decreases by 71.90% lower compared to the previous year.

The Elixxer Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2016
0.08 CAD
Jan 1, 2017
0.02 CAD
Jan 1, 2018
0.19 CAD
Jan 1, 2019
0.14 CAD
Jan 1, 2020
0.05 CAD
Jan 1, 2021
0.09 CAD
Jan 1, 2022
-0.06 CAD
Jan 1, 2023
-0.10 CAD
The Elixxer Book Value per Share history
YEARBook Value per ShareYoY
-0.10CAD+71.90%
-0.06CAD-166.64%
0.09CAD+76.12%
0.05CAD-63.89%
0.14CAD-25.43%
0.19CAD+1,021.23%
0.02CAD-79.12%
0.08CAD+69,817.59%
0.00CAD-97.57%
0.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Elixxer Stock analysis

What does Elixxer do? Elixxer Ltd, trading under the ticker ELXR.H.V and registered with ISIN CA28660W20004, is a company based in Montreal, Canada. It operates within the Financial Services sector, specifically in the Financials industry. The company completed its initial public offering on November 24, 2005. Elixxer Ltd maintains a website at https://www.elixxer.com/. The company's primary focus involves investments in cannabis-related businesses, including entities licensed for the cultivation, production, and sale of cannabis and cannabis-derived products. Its investment portfolio spans various segments of the cannabis industry, such as nutraceuticals, cosmetics, pharmaceuticals, cultivation, and extraction. The firm emphasizes medical cannabis and specialty cannabis-derived products within the pharmaceutical sector. Elixxer Ltd also engages in the cultivation and production of medical-grade cannabis for global markets. Additionally, the company develops and produces Cannabidiol (CBD) cosmetics and natural wellness products. It invests in facilities dedicated to the cultivation, extraction, and production of legal cannabis products. The company's brands include Viridi, Easyjoint, Freia, Little Green Pharma (LGP), and One Premium Cannabis. Elixxer Ltd holds investments in cannabis companies across multiple countries, including Australia, Canada, Switzerland, Italy, and Jamaica. Subsidiaries of the company include LGC Finance Limited, LGC Capital EU OU, and LGC Capital Spain S.L. Elixxer is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Elixxer stock

Book Value per Share of Elixxer is -0.10 CAD in 2023.

Book Value per Share of Elixxer changed from -0.06 CAD to -0.10 CAD, representing a 71.90% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Elixxer since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Elixxer

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Elixxer